Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Sep 12, 2014 sanofi Beneficial Owner (10% or more) Buy 59,808 345.07 - 347.92
Sep 10, 2014 vagelos p roy Officer Automatic Sell 10,326 350.07
Sep 8, 2014 vagelos p roy Officer Automatic Sell 2 351.00
Sep 5, 2014 vagelos p roy Officer Disposition (Non Open Market) 4 n/a
Aug 28, 2014 yancopoulos george Officer Disposition (Non Open Market) 294 n/a
Aug 28, 2014 yancopoulos george Officer Acquisition (Non Open Market) 294 n/a
Aug 27, 2014 goldstein joseph l Director Sell 2,000 350.31
Aug 27, 2014 mccorkle douglas s Officer Option Execute 1,681 21.25 - 30.63
Aug 27, 2014 tessier-lavigne marc Director Sell 3,000 352.20
Aug 27, 2014 tessier-lavigne marc Director Option Execute 3,000 50.91
Aug 27, 2014 yancopoulos george Officer Disposition (Non Open Market) 5,426 351.33
Aug 27, 2014 yancopoulos george Officer Option Execute 5,720 314.31
Aug 26, 2014 tessier-lavigne marc Director Disposition (Non Open Market) 200 351.62
Aug 26, 2014 tessier-lavigne marc Director Option Execute 1,387 50.91
Aug 26, 2014 vagelos p roy Officer Disposition (Non Open Market) 161,597 351.62
Aug 26, 2014 vagelos p roy Officer Option Execute 303,909 11.64
Aug 22, 2014 aberman michael s Officer Option Execute 3,000 24.00
Aug 19, 2014 aberman michael s Officer Automatic Sell 3,611 350.00
Aug 18, 2014 aberman michael s Officer Automatic Sell 5,139 351.06
Aug 18, 2014 aberman michael s Officer Option Execute 8,750 52.03
Showing 181-200 of 1021 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)